<prompt> Monoclonal antibodies to the CD25 IL-2a receptors are used for a treatment of:Hematological neoplasmAutoimmune diseaseBone marrow transplantationKidney transplant rejection  <response>: Antibodies to CD 25 -Basiliximab reduces the incidence and severity of acute rejection in kidney transplantation without increasing the incidence of oppounistic infections. 